Literature DB >> 10229132

Cyclooxygenases-1 and -2 are differentially localized to microglia and endothelium in rat EAE and glioma.

M H Deininger1, H J Schluesener.   

Abstract

Cyclooxygenases (COX) mediate a wide variety of derangements observed during diseases of the brain. Their overexpression is involved in the mediation of inflammation, immunomodulation, blood flow, apoptosis and fever. Here, we have analyzed the localization of COX-1 and COX-2 in rat experimental autoimmune encephalomyelitis (EAE), C6 glioblastoma and 9L gliosarcoma by immunohistochemistry. In healthy brain, COX-1 was expressed in single macrophages/microglial cells. Neurons and few endothelial cells expressed COX-2. In EAE, we observed an increase in COX-1+ macrophages/microglial cells and COX-2+ endothelial cells that was closely linked to disease progression. Both COX-1+ macrophages/microglial cells and COX-2+ endothelial cells were abundant in areas of cellular infiltration. In C6 and 9L tumors, high numbers of COX-1+ macrophages/microglial cells and COX-2+ endothelial cells were found both in the tumor parenchyma and in areas of infiltrative tumor growth. Double labeling experiments confirmed expression of COX-2 in vWF+ (endothelial) cells and COX-1 in ED1+ (macophages), OX6+ (MHC class II) and in W3/13+ (lymphoblasts) cells. These data provide further evidence that expression of COX-1 in macrophages/microglial cells and COX-2 in endothelial cells might represent important regulatory mechanisms in inflammatory processes associated with autoimmunity and neoplasia of the rat brain.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10229132     DOI: 10.1016/s0165-5728(98)00257-4

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  16 in total

1.  Nonsteroidal anti-inflammatory drugs and glioma in the NIH-AARP Diet and Health Study cohort.

Authors:  Sarah E Daugherty; Steven C Moore; Ruth M Pfeiffer; Peter D Inskip; Yikyung Park; Albert Hollenbeck; Preetha Rajaraman
Journal:  Cancer Prev Res (Phila)       Date:  2011-09-01

2.  Cyclooxygenase expression and prostaglandin levels in central nervous system tissues during the course of chronic relapsing experimental autoimmune encephalomyelitis (EAE).

Authors:  Samir S Ayoub; Elizabeth G Wood; Sabih-Ul Hassan; Christopher Bolton
Journal:  Inflamm Res       Date:  2011-06-12       Impact factor: 4.575

3.  Targeted lipidomics reveals mPGES-1-PGE2 as a therapeutic target for multiple sclerosis.

Authors:  Yasuyuki Kihara; Takuya Matsushita; Yoshihiro Kita; Satoshi Uematsu; Shizuo Akira; Jun-ichi Kira; Satoshi Ishii; Takao Shimizu
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-07       Impact factor: 11.205

4.  Cyclooxygenase-1 and -2 in brains of patients who died with sporadic Creutzfeldt-Jakob disease.

Authors:  Martin H Deininger; Kubrom Bekure-Nemariam; Katrin Trautmann; Matthias Morgalla; Richard Meyermann; Hermann J Schluesener
Journal:  J Mol Neurosci       Date:  2003-02       Impact factor: 3.444

5.  Gene expression of cyclooxygenase-1 and Ca(2+)-independent phospholipase A(2) is altered in rat hippocampus during normal aging.

Authors:  Saba Aïd; Francesca Bosetti
Journal:  Brain Res Bull       Date:  2007-03-20       Impact factor: 4.077

Review 6.  Pathophysiological Roles of Cyclooxygenases and Prostaglandins in the Central Nervous System.

Authors:  Tatsurou Yagami; Hiromi Koma; Yasuhiro Yamamoto
Journal:  Mol Neurobiol       Date:  2015-09-02       Impact factor: 5.590

Review 7.  Developing therapeutics for the treatment of multiple sclerosis.

Authors:  David J Virley
Journal:  NeuroRx       Date:  2005-10

8.  An efficient and reproducible method for quantifying macrophages in different experimental models of central nervous system pathology.

Authors:  Dustin J Donnelly; John C Gensel; Daniel P Ankeny; Nico van Rooijen; Phillip G Popovich
Journal:  J Neurosci Methods       Date:  2009-04-23       Impact factor: 2.390

9.  Cerebral arachidonate cascade in dementia: Alzheimer's disease and vascular dementia.

Authors:  Tatsurou Yagami
Journal:  Curr Neuropharmacol       Date:  2006-01       Impact factor: 7.363

10.  Flurbiprofen, a cyclooxygenase inhibitor, reduces the brain arachidonic acid signal in response to the cholinergic muscarinic agonist, arecoline, in awake rats.

Authors:  Mireille Basselin; Nelly E Villacreses; Ho-Joo Lee; Jane M Bell; Stanley I Rapoport
Journal:  Neurochem Res       Date:  2007-06-12       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.